AT&T (NYSE: T) recently unveiled its updated strategic plan, providing investors with financial guidance through 2027. The ...
TD Cowen named Xenon Pharmaceuticals (XENE) a Best Idea for 2025 while keeping a Buy rating on the shares with no price ...
Following Wednesday’s release of third-quarter fiscal 2025 financial results that largely fell in line with his expectations, ...
On Tuesday, Stem Inc (STEM) stock saw a modest uptick, ending the day at $0.38 which represents no change from the prior close of of $0.38. The stock opened at $0.37 and touched a low of $0.36 during ...